|
Richard R. Love, M.D., M.S.
Scientific Director
 Dr. Love is a medical researcher whose focus is on hormonal control of breast cancer. For the last 18 years his NIH and Breast Cancer Research Foundation-funded research has been done in collaboration with colleagues in Vietnam, and more recently in the Philippines, Morocco and Bangladesh.
His clinical trial of adjuvant surgical oophorectomy and tamoxifen established a new global standard of care, of significant importance to 500,000 poor women diagnosed with breast cancer annually around the world.
Currently a major new focus of Dr. Love’s and IBCRF's attention is in developing a model population-based program to reduce morbidity and mortality from breast cancer among the 7 million women residing in the Khulna division of Bangladesh. This program involves educational, service and research projects, in partnership with a rural information technology non-governmental organization. To achieve service sustainability, the program is being developed as a group of “social businesses”, following the entrepreneurial ideas and with the assistance of Muhammad Yunus, the Bangladeshi Nobel Peace Prize Laureate.
Publications:
Review a list of Dr. Love's publications.
Ophira Ginsburg
Deputy Scientific Director
Dr. Ophira Ginsburg is a medical oncologist, and an Adjunct Scientist at Women’s College Research Institute (WCRI). She is an assistant professor at the University of Toronto in the Department of Medicine, and Dalla Lana School of Public Health. Since 2004, her research has focused on understanding population differences in breast cancer risk factors and outcomes. In 2009 she became Deputy Scientific Director for IBCRF. Her research portfolio includes a broad range of “Public Health Oncology” studies, the overarching aim of which is to inform best clinical practicesfor under-served women at home and abroad.
Please refer to Dr Ginsburg’s peer-reviewed publications as indexed in PubMed http://www.ncbi.nlm.nih.gov/pubmed?term=Ginsburg%20O]
MORE SCIENCE IN THE SERVICE TO MAN
A theme of Dr. Love’s work is social justice, and the need for activities to better address public health-population challenges in the face of the evolution of cancer medicine as big business.
 |
From left: Rashed Ahmed (Amader Gram), Dr. Richard R. Love, Professor Muhammad Yunus (Nobel Peace Laureat), Reza Salim (Amader Gram)
| To this end Dr. Love publishes articles in peer-reviewed journals, and lectures widely to lay and professional audiences, more outside than within the United States. In the United States he has called for significant increases in global public health oncology research (“micro-approaches”), comparable to the current efforts in communicable diseases (ASCO Breast Cancer Symposium September 7, 2008; U.S. Department of State and Avon Foundation Breast Cancer Global Congress October 15, 2008).
CURRENT CLINICAL TRIALS
Dr. Love has three major clinical trials investigating new “public health” (i.e. easily replicable, practical, limited toxicity and low cost) treatments for breast cancer in 9 countries; nearly 1,000 usually forgotten poor women have entered these trials to date. He is working with several American and Canadian researchers to develop a larger portfolio of similar international collaborative-public health studies. To carry out this work Dr. Love spends 40% of his time abroad.
For overviews of our current research projects, click here |
|
